PROCEPT BioRobotics(PRCT.US)

Last Updated 19:00:00 ET
longbridge loading

A Look At PROCEPT BioRobotics (PRCT) Valuation As AUA Guideline Update Expands Aquablation Opportunity

Simplywall·
US
PRCT
+4.38%
US
XBI
+1.14%
US
IBB
+0.91%
Simplywall·
US
PRCT
+4.38%
US
XBI
+1.14%
US
IBB
+0.91%

PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen

Tip Ranks·
US
PRCT
+4.38%
US
BIB
+0.08%
US
LABU
+3.31%
Tip Ranks·
US
PRCT
+4.38%
US
BIB
+0.08%
US
LABU
+3.31%

PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.4% - Should You Buy?

Market Beat·
US
PRCT
+4.38%
US
BIB
+0.08%
US
LABU
+3.31%
Market Beat·
US
PRCT
+4.38%
US
BIB
+0.08%
US
LABU
+3.31%

PROCEPT BioRobotics Corporation $PRCT Shares Sold by Comerica Bank

Market Beat·
US
PRCT
+4.38%
US
IHI
-0.42%
US
XHE
+0.28%
Market Beat·
US
PRCT
+4.38%
US
IHI
-0.42%
US
XHE
+0.28%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
AKAN
+84.32%
US
PRCT
+4.38%
US
ANL
+6.16%
benzinga_article·
US
AKAN
+84.32%
US
PRCT
+4.38%
US
ANL
+6.16%

PROCEPT Posts Strong Q1 Growth, Driven By U.S. System Sales And Procedure Expansion

nasdaq·
US
PRCT
+4.38%
US
IHI
-0.42%
US
XHE
+0.28%
nasdaq·
US
PRCT
+4.38%
US
IHI
-0.42%
US
XHE
+0.28%

PROCEPT BioRobotics Q1 Earnings Call Highlights

Market Beat·
US
PRCT
+4.38%
US
XBI
+1.14%
US
XHE
+0.28%
Market Beat·
US
PRCT
+4.38%
US
XBI
+1.14%
US
XHE
+0.28%

PROCEPT BioRobotics shares are trading higher after the company reported better-than-expected Q1 sales results and reaffirmed its FY2026 sales guidance.

benzinga_article·
US
PRCT
+4.38%
US
LABU
+3.31%
US
XHE
+0.28%
benzinga_article·
US
PRCT
+4.38%
US
LABU
+3.31%
US
XHE
+0.28%
© 2026 Longbridge｜Disclaimer